N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide

TargetMol
Product Code: TAR-TN7036
Supplier: TargetMol
CodeSizePrice
TAR-TN7036-10mg10mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7036-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7036-1mg1mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7036-5mg5mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7036-1mL1 mL * 10 mM (in DMSO)£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
N-3-methoxylBenzyllinolenicamide induces osteogenic differentiation and subsequent bone formation of mesenchymal stem cells by activating the canonical Wnt/β-catenin signaling pathway that can be used for osteoporosis research.
CAS:
883715-23-9
Formula:
C52H77N2O4
Molecular Weight:
794.18
Pathway:
Cytoskeletal Signaling; Stem Cells
Purity:
0.9866
SMILES:
CC/C=CC/C=CC/C=CCCCCCCCC(NCc1cc(OC)ccc1)=OCC/C=CC/C=CC/C=CCCCCCCCC(NCc1cc(OC)ccc1)=O
Target:
Wnt/beta-catenin

References

Ting Wang, et al. N-(3-methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide promotes bone formation via the canonical Wnt/?-catenin signaling . pathwayPhytother Res. 2019 Apr;33(4):1074-1083.